Current strategies for the design of PROTAC linkers: a critical review
PROteolysis TArgeting Chimeras (PROTACs) are heterobifunctional molecules consisting of two ligands; an “anchor” to bind to an E3 ubiquitin ligase and a “warhead” to bind to a protein of interest, connected by a chemical linker. Targeted protein degradation by PROTACs has emerged as a new modality for the knock down of a range of proteins, with the first agents now reaching clinical evaluation. It has become increasingly clear that the length and composition of the linker play critical roles on the physicochemical properties and bioactivity of PROTACs. While linker design has historically received limited attention, the PROTAC field is evolving rapidly and currently undergoing an important shift from synthetically tractable alkyl and polyethylene glycol to more sophisticated functional linkers. This promises to unlock a wealth of novel PROTAC agents with enhanced bioactivity for therapeutic intervention. Here, the authors provide a timely overview of the diverse linker classes in the published literature, along with their underlying design principles and overall influence on the properties and bioactivity of the associated PROTACs. Finally, the authors provide a critical analysis of current strategies for PROTAC assembly. The authors highlight important limitations associated with the traditional “trial and error” approach around linker design and selection, and suggest potential future avenues to further inform rational linker design and accelerate the identification of optimised PROTACs. In particular, the authors believe that advances in computational and structural methods will play an essential role to gain a better understanding of the structure and dynamics of PROTAC ternary complexes, and will be essential to address the current gaps in knowledge associated with PROTAC design.
Top-30
Citations by journals
5
10
15
20
25
|
|
Journal of Medicinal Chemistry
22 publications, 14.01%
|
|
European Journal of Medicinal Chemistry
11 publications, 7.01%
|
|
Molecules
5 publications, 3.18%
|
|
Bioorganic and Medicinal Chemistry Letters
5 publications, 3.18%
|
|
Nature Communications
5 publications, 3.18%
|
|
Cell Chemical Biology
4 publications, 2.55%
|
|
ACS Medicinal Chemistry Letters
4 publications, 2.55%
|
|
Journal of the American Chemical Society
3 publications, 1.91%
|
|
Future Medicinal Chemistry
3 publications, 1.91%
|
|
Advanced Science
3 publications, 1.91%
|
|
ChemBioChem
3 publications, 1.91%
|
|
ACS Chemical Biology
3 publications, 1.91%
|
|
Chemistry - A European Journal
3 publications, 1.91%
|
|
Pharmaceutics
3 publications, 1.91%
|
|
Nature Reviews Drug Discovery
2 publications, 1.27%
|
|
Cancers
2 publications, 1.27%
|
|
International Journal of Molecular Sciences
2 publications, 1.27%
|
|
Frontiers in Cell and Developmental Biology
2 publications, 1.27%
|
|
Journal of Biomedical Science
2 publications, 1.27%
|
|
Computational and Structural Biotechnology Journal
2 publications, 1.27%
|
|
Bioorganic and Medicinal Chemistry
2 publications, 1.27%
|
|
Journal of Chemical Information and Modeling
2 publications, 1.27%
|
|
Medicinal Research Reviews
2 publications, 1.27%
|
|
Chemical Society Reviews
2 publications, 1.27%
|
|
Chemical Communications
2 publications, 1.27%
|
|
Archiv der Pharmazie
2 publications, 1.27%
|
|
Mendeleev Communications
1 publication, 0.64%
|
|
Frontiers in Molecular Biosciences
1 publication, 0.64%
|
|
BioDrugs
1 publication, 0.64%
|
|
5
10
15
20
25
|
Citations by publishers
5
10
15
20
25
30
35
40
|
|
American Chemical Society (ACS)
38 publications, 24.2%
|
|
Elsevier
37 publications, 23.57%
|
|
Wiley
18 publications, 11.46%
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
16 publications, 10.19%
|
|
Springer Nature
15 publications, 9.55%
|
|
Royal Society of Chemistry (RSC)
8 publications, 5.1%
|
|
Frontiers Media S.A.
5 publications, 3.18%
|
|
Future Medicine
2 publications, 1.27%
|
|
Bentham Science
2 publications, 1.27%
|
|
Taylor & Francis
2 publications, 1.27%
|
|
IOP Publishing
1 publication, 0.64%
|
|
Cambridge University Press
1 publication, 0.64%
|
|
Open Exploration Publishing
1 publication, 0.64%
|
|
Oxford University Press
1 publication, 0.64%
|
|
Cold Spring Harbor Laboratory
1 publication, 0.64%
|
|
American Association for Cancer Research (AACR)
1 publication, 0.64%
|
|
5
10
15
20
25
30
35
40
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.